Back to News
Retail news

FDA To Decide If Mevacor Goes OTC

Advisors are expected to decide today whether or not to approve Mevacor, a cholesterol-lowering medication, for sale over-the-counter.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0